source
- EU regulator backs Novo's hemophilia A preventive therapy and recommends seven additional drugsThe European Medicines Agency's human medicines committee issued a positive opinion on Novo's preventive treatment for hemophilia A, indicating it meets the agency's standards for further developme…
- Electra Therapeutics raises $350M in IPO to fund pivotal immune-disease antibody developmentElectra Therapeutics announced an initial public offering that raised $350 million, exceeding its earlier target. The IPO consisted of 23.3 million shares sold at $15 per share, and underwriters w…